reglab/housing_qa huggingface dataset:
MD. Health - General Code Ann. §  24-806 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 8 - Aids Prevention Sterile Needle and Syringe Exchange Pilot Program|Section 24-806 - Collection of Data; Evaluation of Particular Issues; Methodology

    (a)    The Baltimore City Health Department shall include in its Program operating procedures measures to collect the following data:        (1)    The number of participants served by the Program;        (2)    The length of time a participant is served by the Program;        (3)    Demographic profiles of participants served by the Program that include:            (i)    Age;            (ii)    Sex;            (iii)    Race;            (iv)    Occupation;            (v)    Zip code of residence;            (vi)    Types of drugs used;            (vii)    Length of drug use; and            (viii)    Frequency of injection;        (4)    The number of hypodermic needles and syringes exchanged;        (5)    The number of participants entering drug counseling and treatment; and        (6)    The number of referrals made by the Program for drug counseling and treatment.    (b)    With the advice and approval of the oversight committee, the Baltimore City Health Department shall develop and implement a plan for Program evaluation that shall include the following issues:        (1)    The prevalence of HIV among Program participants;        (2)    Changes in the level of drug use among Program participants;        (3)    Changes in the level of needle–sharing among Program participants;        (4)    Changes in the use of condoms among Program participants;        (5)    The status of treatment and recovery for Program participants who entered drug treatment programs;        (6)    The impact of the Program on risk behaviors for the transmission of the HIV infection, the hepatitis B virus, and other life–threatening blood–borne diseases among injecting drug users;        (7)    The cost–effectiveness of the Program versus the direct and indirect costs of the HIV infection in terms of medical treatment and other services normally required by HIV–infected individuals;        (8)    The strengths and weaknesses of the Program; and        (9)    The advisability of continuing the Program.    (c)    As part of its plans for data collection and Program evaluation described under subsections (a) and (b) of this section, the Baltimore City Health Department shall develop and implement a methodology:        (1)    For identifying Program hypodermic needles and syringes, such as through the use of bar coding or any other method approved by the oversight committee; and        (2)    To perform HIV antibody testing on the residue left in a sample of hypodermic needles and syringes returned to the Program.    (d)    On or before December 31 of each year, the Baltimore City Health Department shall report to the oversight committee, the Governor, and, in accordance with § 2–1257 of the State Government Article, the General Assembly, on the number of hypodermic needles and syringes exchanged as part of the Program.
MD. Health - General Code Ann. §  24-807 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 8 - Aids Prevention Sterile Needle and Syringe Exchange Pilot Program|Section 24-807 - Participant Identification; Confidentiality

    (a)    (1)    Each Program participant shall be issued an identification card with an identification number.        (2)    The identification number shall be cross-indexed to a confidential record containing pertinent data on the participant.    (b)    Any information obtained by the Program that would identify Program participants, including Program records, is:        (1)    Confidential;        (2)    Not open to public inspection or disclosure; and        (3)    Not discoverable in any criminal or civil proceeding.    (c)    (1)    Notwithstanding the provisions of subsection (b) of this section, upon the written consent of a Program participant, information obtained by the Program that identifies the Program participant may be released or disclosed to a person or agency participating in the Program.        (2)    In addition to the provisions of paragraph (1) of this subsection, if a Program participant raises the issue of participation in the Program either as a subject matter or legal defense in an administrative, civil, or criminal proceeding, the Program participant waives the confidentiality as to identity provided under subsection (b)(1) of this section.
MD. Health - General Code Ann. §  24-808 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 8 - Aids Prevention Sterile Needle and Syringe Exchange Pilot Program|Section 24-808 - Criminal Liability Concerning Distribution of Controlled Paraphernalia

    (a)    No Program staff member or Program participant may be found guilty of violating § 5-601, § 5-619, § 5-620, § 5-902, or § 5-904 of the Criminal Law Article for possessing or distributing controlled paraphernalia or drug paraphernalia whenever the possession or distribution of the controlled paraphernalia or drug paraphernalia is a direct result of the employee’s or participant’s activities in connection with the work of the Program authorized under this subtitle.    (b)    Notwithstanding the provisions of subsection (a) of this section, a Program staff member or Program participant is not immune from criminal prosecution for:        (1)    The redistribution of hypodermic needles or syringes in any form;        (2)    Any activities not authorized or approved by the Program; or        (3)    The possession or distribution of controlled paraphernalia or drug paraphernalia or any other unlawful activity outside of the Baltimore City limits.
MD. Health - General Code Ann. §  24-809 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 8 - Aids Prevention Sterile Needle and Syringe Exchange Pilot Program|Section 24-809 - Criminal Liability for Use, Possession, and Distribution of Controlled Substances

    Except for violations of any laws that could arise from residue attached to or contained within hypodermic needles or syringes being returned or already returned to the Program, nothing in this subtitle provides immunity to a Program staff member or Program participant from criminal prosecution for a violation of any law prohibiting or regulating the use, possession, dispensing, distribution, or promotion of controlled dangerous substances, dangerous drugs, detrimental drugs, or harmful drugs or any conspiracy or attempt to commit any of those offenses.
MD. Health - General Code Ann. §  24-901 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 9 - Opioid-Associated Disease Prevention and Outreach Programs|Section 24-901 - Definitions

    (a)    In this subtitle the following words have the meanings indicated.    (b)    “Community–based organization” means a public or private organization that is representative of a community or significant segments of a community and provides educational, health, or social services to individuals in the community.    (c)    “Drug” has the meaning stated in § 8–101 of this article.    (d)    “HIV” means the human immunodeficiency virus that causes acquired immune deficiency syndrome (AIDS).    (e)    “Participant” means an individual who has registered with a Program.    (f)    “Program” means an Opioid–Associated Disease Prevention and Outreach Program.    (g)    “Residue” means the remains of a controlled dangerous substance attached to or contained within a hypodermic needle or syringe.    (h)    “Substance–related disorder” has the meaning stated in § 7.5–101 of this article.    (i)    “Viral hepatitis” means inflammation of the liver caused by the hepatitis A, B, C, D, and E viruses.
MD. Health - General Code Ann. §  24-902 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 9 - Opioid-Associated Disease Prevention and Outreach Programs|Section 24-902 - Establishment of Programs

    (a)    (1)    A Program may be established by a local health department or a community–based organization, subject to the provisions of this subtitle.        (2)    (i)    A county may cooperate with another county to establish a Program.            (ii)    A community–based organization may establish a multicounty Program.        (3)    This subtitle does not apply to the AIDS Prevention Sterile Needle and Syringe Exchange Pilot Program established under Subtitle 8 of this title.    (b)    (1)    (i)    A local health department or community–based organization shall apply to the Department and a local health officer for authorization to operate a Program.            (ii)    A local health department or community–based organization may apply at any time for authorization to operate a Program under subparagraph (i) of this paragraph.        (2)    The Department and a local health officer jointly shall issue an authorization determination based on the ability of a Program to meet the requirements of this subtitle.        (3)    The Department and a local health officer shall:            (i)    Approve or deny an application for authorization to operate a Program within 60 days after receiving a complete application; and            (ii)    Provide to the applicant a written explanation of the decision of the Department and local health officer.        (4)    (i)    A local health department or community–based organization may appeal an adverse decision by the Department and a local health officer to the Deputy Secretary for Public Health Services.            (ii)    The Deputy Secretary shall:                1.    Grant or deny an appeal within 60 days after receiving an appeal; and                2.    Provide a written explanation of the Deputy Secretary’s decision to the local health department or community–based organization.    (c)    If established under subsection (a) of this section, a Program shall:        (1)    Provide for substance use outreach, education, and linkage to treatment services to participants, including distribution and collection of hypodermic needles and syringes; and        (2)    Operate in accordance with:            (i)    The technical assistance of the Standing Advisory Committee; and            (ii)    The procedures, plans, and protocols approved by:                1.    The local health officer for each county in which a Program is established; and                2.    The Department.
MD. Health - General Code Ann. §  24-904 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 9 - Opioid-Associated Disease Prevention and Outreach Programs|Section 24-904 - Standing Advisory Committee on Opioid-Associated Disease Prevention and Outreach Programs

    (a)    The Department shall appoint a Standing Advisory Committee on Opioid–Associated Disease Prevention and Outreach Programs.    (b)    The Standing Advisory Committee shall consist of:        (1)    The Deputy Secretary for Public Health Services;        (2)    One individual from academia who specializes in public health issues related to substance–related disorders or infectious diseases;        (3)    One representative from law enforcement, nominated by the Executive Director of the Governor’s Office of Crime Prevention, Youth, and Victim Services;        (4)    One individual with expertise in the prevention of HIV or viral hepatitis;        (5)    One health care practitioner with experience providing services to individuals who inject drugs;        (6)    One individual with substance use experience;        (7)    One family member of an individual who injects or has injected drugs;        (8)    One representative of local law enforcement;        (9)    One local health officer;        (10)    One representative of a local or regional hospital;        (11)    One individual with experience in syringe services programs; and        (12)    Any additional members recommended by the Department.    (c)    The Deputy Secretary for Public Health Services shall serve as chair of the Standing Advisory Committee.    (d)    The Standing Advisory Committee shall:        (1)    Provide technical assistance to each Program on developing:            (i)    Program operating procedures for collection and distribution of hypodermic needles and syringes;            (ii)    A plan for community outreach and education; and            (iii)    A protocol for linking Program participants to substance–related disorder treatment and recovery services; and        (2)    Make recommendations to a Program regarding any aspect of Program procedures or operation.
MD. Health - General Code Ann. §  24-905 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 9 - Opioid-Associated Disease Prevention and Outreach Programs|Section 24-905 - Duties of Department

    (a)    The Department shall:        (1)    Adopt regulations for the implementation of this subtitle, in consultation with the Standing Advisory Committee and the Maryland Association of County Health Officers; and        (2)    Ensure the provision of technical assistance to a Program about best practices, best practice protocols, and other subject areas.    (b)    The regulations adopted under subsection (a)(1) of this section shall establish:        (1)    Procedures for ensuring the security of Program locations and equipment;        (2)    An appeals process for appeals authorized by § 29–902(b)(4) of this subtitle, including the standard of review that the Deputy Secretary for Public Health Services must apply when reviewing a decision of the Department and a local health officer; and        (3)    Procedures for data collection and Program evaluation.
MD. Health - General Code Ann. §  24-906 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 9 - Opioid-Associated Disease Prevention and Outreach Programs|Section 24-906 - Identification of Participants; Confidentiality of Information

    (a)    (1)    Each Program participant shall be issued a unique identification card with a unique identification number.        (2)    The unique identification number may not be cross–indexed to any personal identifying data on the participant.    (b)    Any information obtained by a Program that identifies Program participants, including Program records, is:        (1)    Confidential;        (2)    Not open to public inspection or disclosure; and        (3)    Not discoverable in any criminal or civil proceeding.    (c)    (1)    Notwithstanding the provisions of subsection (b) of this section, on the written consent of a Program participant, information obtained by a Program that identifies the Program participant may be released or disclosed to an individual or agency for purposes of linking to services under § 24–903(a)(6) of this subtitle.        (2)    In addition to the provisions of paragraph (1) of this subsection, if a Program participant raises the issue of participation in a Program either as a subject matter or legal defense in an administrative, civil, or criminal proceeding, the Program participant waives the confidentiality as to identity provided under subsection (b) of this section.        (3)    Substance–related treatment records requested or provided under this section are subject to any additional limitations on disclosure or re–disclosure of a medical record developed in connection with the provision of substance–related treatment services under State law or 42 U.S.C. § 290dd–2 and 42 C.F.R. Part 2.
MD. Health - General Code Ann. §  24-907 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 9 - Opioid-Associated Disease Prevention and Outreach Programs|Section 24-907 - Data Collection and Reporting

    A Program shall collect and report at least annually the following data to the Department:        (1)    The number of participants served by the Program;        (2)    The number of new participants registered by the Program during the reporting period;        (3)    Demographic profiles of participants served by the Program, including:            (i)    Age;            (ii)    Gender;            (iii)    Race;            (iv)    Zip code; and            (v)    Types of drugs used;        (4)    The number of hypodermic needles and syringes distributed and collected;        (5)    Each location at which hypodermic needles and syringes were distributed; and        (6)    The number of linkages provided to participants under § 24–903(a)(6) of this subtitle.
MD. Health - General Code Ann. §  24-908 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 9 - Opioid-Associated Disease Prevention and Outreach Programs|Section 24-908 - Immunity From Prosecution; Permitted Prosecutions

    (a)    A Program staff member, Program volunteer, or Program participant may not be arrested, charged, or prosecuted for violating § 5–601, § 5–619, § 5–620, or § 5–902(c) or (d) of the Criminal Law Article for possessing or distributing controlled paraphernalia or drug paraphernalia whenever the possession or distribution of the controlled paraphernalia or drug paraphernalia is a direct result of the employee’s, volunteer’s, or participant’s activities in connection with the work of a Program authorized under this subtitle.    (b)    Notwithstanding the provisions of subsection (a) of this section, a Program staff member, Program volunteer, or Program participant is not immune from criminal prosecution for any activities not authorized or approved by a Program.
MD. Health - General Code Ann. §  24-909 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 9 - Opioid-Associated Disease Prevention and Outreach Programs|Section 24-909 - No Immunity From Drug-Related Criminal Prosecutions; Exceptions

    Except for violations of any laws that could arise from residue attached to or contained within hypodermic needles or syringes being returned or already returned to a Program, nothing in this subtitle provides immunity to a Program staff member, Program volunteer, or Program participant from criminal prosecution for a violation of any law prohibiting or regulating the use, possession, dispensing, distribution, or promotion of controlled dangerous substances, dangerous drugs, detrimental drugs, or harmful drugs or any conspiracy or attempt to commit any of those offenses.
MD. Health - General Code Ann. §  24-1001 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 10 - Assisted Living Facilities Grant Program|Section 24-1001 - Definitions

    (a)    In this subtitle the following words have the meanings indicated.    (b)    “Assisted living facility” means a residential facility or facility-based program that:        (1)    Meets the definition in § 19-1801 of this article; and        (2)    Is licensed by the Department.    (c)    “Facility” means an assisted living facility that is wholly owned by and operated under the authority of:        (1)    A county;        (2)    A municipal corporation; or        (3)    A nonprofit organization.    (d)    “Nonprofit organization” means:        (1)    A bona fide religious organization, no part of the earnings of which inures to the benefit of any individual or is used for any purpose other than the maintenance and operation of a facility, the purchase of equipment to be used in a facility, or the expansion of a facility; or        (2)    An organization:            (i)    That is chartered as a nonprofit corporation and classified by the Internal Revenue Service as nonprofit; and            (ii)    No part of the earnings of which inures to the benefit of any individual or is used for any purpose other than the maintenance and operation of a facility, the purchase of equipment to be used in a facility, or the expansion of a facility.    (e)    “Wholly owned” includes leased, if:        (1)    (i)    The lease is for a minimum term of 30 years following project completion; or            (ii)    The lease agreement extends the right of purchase to the lessee; and        (2)    The lessor consents to the recording in the land records of the county or Baltimore City in which the facility is located, of a notice of the State’s right of recovery as provided under § 24-1006 of this subtitle.
MD. Health - General Code Ann. §  24-1002 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 10 - Assisted Living Facilities Grant Program|Section 24-1002 - Grants -- Purposes

    On the recommendation of the Secretary, the Board of Public Works may make grants to counties, municipal corporations, and nonprofit organizations for:         (1)    The conversion of public buildings or parts of buildings to assisted living facilities;        (2)    The acquisition of existing buildings or parts of buildings for use as assisted living facilities;        (3)    The renovation of assisted living facilities;        (4)    The purchase of capital equipment for assisted living facilities; or        (5)    The planning, design, and construction of assisted living facilities.
MD. Health - General Code Ann. §  24-1003 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 10 - Assisted Living Facilities Grant Program|Section 24-1003 - Application for Grants

    (a)    Any county, municipal corporation, or nonprofit organization sponsoring a project involving work specified in § 24-1002 of this subtitle may apply to the Secretary for a State grant to be applied toward the cost of that project.    (b)    On approval of a project and the project plans by the Department, the Secretary shall promptly report the application to the Board of Public Works, together with the Secretary’s recommendation that the Board make funds available as provided in this subtitle.
MD. Health - General Code Ann. §  24-1005 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 10 - Assisted Living Facilities Grant Program|Section 24-1005 - Allocations -- Available Funds; Certification

    (a)    The Board of Public Works shall make allocations from funds available under this subtitle in accordance with this subtitle.    (b)    The Board shall certify the allocations to the proper State officers, and the Treasurer shall make payments to or on behalf of the applicant, when needed, for the approved project.    (c)    The Board of Public Works may adopt regulations to implement this section.
MD. Health - General Code Ann. §  24-1007 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 10 - Assisted Living Facilities Grant Program|Section 24-1007 - Regulations

    The Department shall adopt regulations to implement the provisions of this subtitle.
MD. Health - General Code Ann. §  24-1101 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 11 - Community Services Trust Fund|Section 24-1101 - Definitions

    (a)    In this subtitle the following words have the meanings indicated.    (b)    “Proceeds” means the gross proceeds minus the costs associated with the sale, lease, or disposition of property and equipment, as determined by the Department of General Services.    (c)    “Trust Fund” means the Community Services Trust Fund.
MD. Health - General Code Ann. §  24-1102 (2021)
2021 Maryland Statutes|Health - General|Title 24 - Miscellaneous Provisions|Subtitle 11 - Community Services Trust Fund|Section 24-1102 - Established; Purpose

    (a)    There is a Community Services Trust Fund in the Office of the Treasurer.    (b)    The purpose of the Trust Fund is to receive and hold the proceeds from the sale or long–term lease of property and equipment of a Developmental Disabilities Administration facility or a Behavioral Health Administration facility.